Today is #StopWoundInfectionDay. #SSIs are the third most commonly reported type of healthcare-acquired infection and the most costly. #Leukomed #Sorbact is clinically proven to reduce #SSI rates.

Having seen the Real World data being delivered, this event is a great opportunity to understand what a simple change in practice can do for reducing rates of SSI following C section, reducing costs and significantly enhancing quality of life for new mums.